$131 Million is the total value of Burrage Capital Management LLC's 25 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PLX | New | PROTALIX BIOTHERAPEUTICS INC | $8,967,000 | – | 2,470,332 | +100.0% | 6.83% | – |
BCRX | New | BIOCRYST PHARMACEUTICALS INC | $8,237,000 | – | 1,105,673 | +100.0% | 6.28% | – |
INZY | New | INOZYME PHARMA INC | $3,525,000 | – | 170,796 | +100.0% | 2.69% | – |
NTLA | New | INTELLIA THERAPEUTICS INC | $3,486,000 | – | 64,079 | +100.0% | 2.66% | – |
MIRM | New | MIRUM PHARMACEUTICALS INC | $2,822,000 | – | 161,628 | +100.0% | 2.15% | – |
AVRO | New | AVROBIO INC | $2,031,000 | – | 145,715 | +100.0% | 1.55% | – |
BDTX | New | BLACK DIAMOND THERAPEUTICS I | $1,118,000 | – | 34,891 | +100.0% | 0.85% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
EPIZYME INC COM | 7 | Q2 2021 | 15.9% |
NeoGenomics Inc | 7 | Q2 2021 | 8.7% |
OrthoPediatrics Corp | 7 | Q2 2021 | 7.3% |
Y-MABS THERAPEUTICS INC COM | 7 | Q2 2021 | 4.3% |
CRINETICS PHARMACEUTICALS INC COM | 7 | Q2 2021 | 5.6% |
G1 THERAPEUTICS INC COM | 7 | Q2 2021 | 7.3% |
PTC THERAPEUTICS INC COM | 6 | Q1 2021 | 8.0% |
CYTOKINETICS INC COM NEW | 6 | Q2 2021 | 4.9% |
TURNING PT THERAPEUTICS INC COM | 6 | Q2 2021 | 6.7% |
APELLIS PHARMACEUTICALS INC COM | 6 | Q1 2021 | 3.5% |
View Burrage Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Protalix BioTherapeutics, Inc.Sold out | July 30, 2021 | 0 | 0.0% |
IVERIC bio, Inc. | February 14, 2020 | 10 | 3.4% |
View Burrage Capital Management LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2021-11-15 |
13F-HR | 2021-08-16 |
SC 13G/A | 2021-07-30 |
13F-HR | 2021-05-17 |
13F-HR | 2021-02-12 |
SC 13G | 2021-02-12 |
13F-HR | 2020-11-13 |
13F-HR | 2020-08-14 |
13F-HR | 2020-05-14 |
13F-HR | 2020-02-14 |
View Burrage Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.